The NRF2 transcription factor (nuclear factor-erythroid 2 p45-related factor 2) has been identified as a key molecular player in orchestrating adaptive cellular interactions following a wide spectrum of cellular stress conditions that could be either extracellular or intracellular. Dysregulation of the NRF2 system is implicated in various disease states, including inflammatory conditions. The NRF2 transcription factor is also known to permit cross talk with several other essential cellular signaling pathways. Recent literature has also elucidated the potential influences of miRNA activity over modulations of the NRF2 signalling network. Consequently, further delving into the knowledge regarding the extent of miRNA-induced epigenetic gene regulatory control on key elements of the NRF2 signalling pathway and its cross talk, particularly within the context of cancer models, can prove to be of high clinical importance. This is so since such miRNAs, once identified and validated, can be potentially exploited as novel drug targets for emerging translational medicine-based therapies.
Keyphrases
- oxidative stress
- transcription factor
- nuclear factor
- papillary thyroid
- diabetic rats
- signaling pathway
- toll like receptor
- healthcare
- systematic review
- gene expression
- squamous cell
- dna methylation
- risk assessment
- squamous cell carcinoma
- immune response
- drug induced
- high glucose
- inflammatory response
- endothelial cells
- electronic health record